Taiyo Names New President Amid Quality Scandal
This article was originally published in PharmAsia News
Nagoya-based Taiyo Pharmaceutical President Shigeki Aratani will step down from a 36-year reign of the company following quality violations
You may also be interested in...
BeiGene gets a new chief business executive and there are new CMOs at Cellectar Biopharma, MacroGenics and Reata Pharmaceuticals.
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.
The Nordic region’s vibrant life sciences ecosystem will be the chief focus for newly created Eir Ventures, a strategic partnership and investment company.